Methods and compositions for nanoparticle-mediated cancer cell-targeted delivery

Details for Australian Patent Application No. 2011205629 (hide)

Owner Board Of Regents, University Of Texas System

Inventors Yuan, Zhi-Min; Seo, Seog-Jin

Agent Fisher Adams Kelly

Pub. Number AU-A-2011205629

PCT Pub. Number WO2011/088456

Priority 61/295,898 18.01.10 US

Filing date 18 January 2011

Wipo publication date 21 July 2011

International Classifications

A61K 47/48 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 9/127 Medicinal preparations characterised by special physical form - Liposomes

A61K 9/48 Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 47/30 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds

A61K 48/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 49/08 Preparations for testing

A61P 35/00 Antineoplastic agents

Event Publications

23 August 2012 PCT application entered the National Phase

  PCT publication WO2011/088456 Priority application(s): WO2011/088456

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011205631-Brine seal for a filtration device

2011205622-Visible light absorbers for ophthalmic lens materials